Home301333 • SHE
add
R&G PharmaStudies Co Ltd
Previous close
¥44.68
Day range
¥44.15 - ¥45.75
Year range
¥33.05 - ¥73.08
Market cap
4.27B CNY
Avg Volume
2.93M
P/E ratio
30.11
Dividend yield
-
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 182.08M | -7.44% |
Operating expense | 11.13M | -82.66% |
Net income | 55.80M | 52.16% |
Net profit margin | 30.65 | 64.43% |
Earnings per share | — | — |
EBITDA | 46.53M | 106.11% |
Effective tax rate | 7.73% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.78B | 4.25% |
Total assets | 2.34B | 12.65% |
Total liabilities | 500.09M | 56.69% |
Total equity | 1.84B | — |
Shares outstanding | 95.14M | — |
Price to book | 2.32 | — |
Return on assets | 4.81% | — |
Return on capital | 5.87% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 55.80M | 52.16% |
Cash from operations | 49.36M | -22.15% |
Cash from investing | 335.97M | 788.65% |
Cash from financing | -10.74M | -203.40% |
Net change in cash | 377.72M | 3,737.60% |
Free cash flow | 87.15M | 38.69% |
About
Founded
Aug 22, 2008
Website
Employees
2,208